| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $234.6M | +157.0% |
| R&D Expense | $136.0M | -17.0% |
| SG&A Expense | $50.7M | +19.7% |
| Operating Income | $47.9M | +141.7% |
| Pre-tax Income | -$13.1M | +91.0% |
| Income Tax | $164K | +5366.7% |
| Net Income | -$13.2M | +90.9% |
| EPS (Basic) | -$0.46 | +91.0% |
| EPS (Diluted) | -$0.46 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $238.2M | +93.5% |
| Accounts Receivable | $33.9M | -17.0% |
| Current Assets | $350.3M | -18.9% |
| Total Assets | $364.4M | -24.7% |
| Current Liabilities | $38.6M | -15.0% |
| Stockholders' Equity | $37.2M | -47.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $19.7M | +114.6% |
| Capital Expenditures | $87K | -75.7% |
| Investing Cash Flow | $228.0M | +139.0% |
| Financing Cash Flow | -$132.6M | -204.4% |
| Free Cash Flow | $19.6M | +114.5% |
| +91.0% |